For the quarter ended September 2024, Dolby Laboratories (DLB) reported income of $304.81 million, up 4.9% over the identical interval final yr. EPS got here in at $0.81, in comparison with $0.65 within the year-ago quarter.
The reported income compares to the Zacks Consensus Estimate of $305.82 million, representing a shock of -0.33%. The corporate delivered an EPS shock of +19.12%, with the consensus EPS estimate being $0.68.
Whereas traders scrutinize income and earnings modifications year-over-year and the way they examine with Wall Avenue expectations to find out their subsequent transfer, some key metrics at all times supply a extra correct image of an organization’s monetary well being.
As these metrics affect top- and bottom-line efficiency, evaluating them to the year-ago numbers and what analysts estimated helps traders undertaking a inventory’s value efficiency extra precisely.
Right here is how Dolby Laboratories carried out within the simply reported quarter by way of the metrics most generally monitored and projected by Wall Avenue analysts:
- Income- Services: $22.10 million versus $25.61 million estimated by three analysts on common. In comparison with the year-ago quarter, this quantity represents a -12.9% change.
- Income- Licensing: $282.71 million in comparison with the $280.21 million common estimate based mostly on three analysts. The reported quantity represents a change of +6.6% yr over yr.
- Gross Margin- Licensing: $263.94 million in comparison with the $265.12 million common estimate based mostly on three analysts.
- Gross margin- Services: $6.87 million versus $3.25 million estimated by three analysts on common.
View all Key Company Metrics for Dolby Laboratories here>>>
Shares of Dolby Laboratories have returned -3.9% over the previous month versus the Zacks S&P 500 composite’s +0.6% change. The inventory presently has a Zacks Rank #3 (Maintain), indicating that it may carry out in keeping with the broader market within the close to time period.
7 Finest Shares for the Subsequent 30 Days
Simply launched: Consultants distill 7 elite shares from the present record of 220 Zacks Rank #1 Robust Buys. They deem these tickers “Most Doubtless for Early Value Pops.”
Since 1988, the total record has overwhelmed the market greater than 2X over with a mean acquire of +23.7% per yr. So make sure you give these hand picked 7 your quick consideration.
Dolby Laboratories (DLB) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.
